AI Engines For more Details: Perplexity Kagi Labs You
Antibacterial Activity: Thiamphenicol exhibits broad-spectrum antibacterial activity against both gram-positive and gram-negative bacteria. It inhibits bacterial protein synthesis by binding to the bacterial ribosome, similar to chloramphenicol.
Indications: Thiamphenicol is used to treat various bacterial infections, including respiratory tract infections (such as pneumonia and bronchitis), urinary tract infections, skin and soft tissue infections, eye infections, ear infections, and certain sexually transmitted infections.
Dosage Forms: Thiamphenicol is available in various dosage forms, including oral tablets, capsules, and suspensions, as well as topical formulations for skin and eye infections.
Alternative to Chloramphenicol: Thiamphenicol is structurally related to chloramphenicol but lacks the potential for causing aplastic anemia, which is a rare but serious adverse effect associated with chloramphenicol use. Therefore, thiamphenicol may be considered as an alternative to chloramphenicol in cases where chloramphenicol is contraindicated or not tolerated.
Side Effects: Common side effects of thiamphenicol may include gastrointestinal symptoms (such as nausea, vomiting, diarrhea, and abdominal pain), allergic reactions (such as rash, itching, and swelling), and hematologic abnormalities (such as reversible bone marrow suppression and transient leukopenia).
Bone Marrow Suppression: Thiamphenicol, like chloramphenicol, has the potential to cause bone marrow suppression, including reversible suppression of erythropoiesis (resulting in anemia), leukopoiesis (resulting in leukopenia), and thrombopoiesis (resulting in thrombocytopenia). Regular monitoring of blood cell counts is recommended during thiamphenicol therapy.
Pregnancy and Lactation: Thiamphenicol should be used with caution during pregnancy and lactation, as its safety profile in these populations has not been well established. The potential benefits of thiamphenicol therapy should be weighed against the potential risks to the fetus or infant.
Children and Elderly: Thiamphenicol is generally not recommended for use in children under certain ages or in elderly individuals due to the risk of bone marrow suppression and other adverse effects.
Renal and Hepatic Impairment: Dose adjustments may be necessary in patients with renal or hepatic impairment, as thiamphenicol is primarily eliminated by the kidneys and liver.
Drug Interactions: Thiamphenicol may interact with other medications, including anticoagulants, antidiabetic agents, and certain anticonvulsants, leading to altered drug levels and potential toxicity or decreased efficacy.
Rank | Probiotic | Impact |
---|---|---|
species | Akkermansia muciniphila | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.5 | 0.5 | |
Acne | 0.5 | -0.5 | |
ADHD | 7.5 | 1 | 6.5 |
Age-Related Macular Degeneration and Glaucoma | 1 | 0.5 | 1 |
Allergic Rhinitis (Hay Fever) | 3 | 2.5 | 0.2 |
Allergies | 7.5 | 3.5 | 1.14 |
Allergy to milk products | 2.5 | 1.5 | 0.67 |
Alopecia (Hair Loss) | 2.5 | 2.5 | |
Alzheimer's disease | 6.5 | 10 | -0.54 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 6 | 2.5 | 1.4 |
Ankylosing spondylitis | 5.5 | 3 | 0.83 |
Anorexia Nervosa | 0.5 | 3.5 | -6 |
Antiphospholipid syndrome (APS) | 3.5 | 0.5 | 6 |
Asthma | 2 | 2.5 | -0.25 |
Atherosclerosis | 2 | 3.5 | -0.75 |
Atrial fibrillation | 5.5 | 2.5 | 1.2 |
Autism | 15.5 | 14.5 | 0.07 |
Barrett esophagus cancer | 1 | 0.5 | 1 |
benign prostatic hyperplasia | 0.5 | 0.5 | |
Bipolar Disorder | 2.5 | 2.5 | 0 |
Brain Trauma | 1 | 1 | 0 |
Carcinoma | 6 | 4 | 0.5 |
Celiac Disease | 4 | 6.5 | -0.63 |
Cerebral Palsy | 2.5 | 2 | 0.25 |
Chronic Fatigue Syndrome | 9 | 10 | -0.11 |
Chronic Kidney Disease | 4 | 3 | 0.33 |
Chronic Lyme | 1 | -1 | |
Chronic Obstructive Pulmonary Disease (COPD) | 3.5 | 1.5 | 1.33 |
Chronic Urticaria (Hives) | 3 | 2 | 0.5 |
Coagulation / Micro clot triggering bacteria | 2.5 | 2 | 0.25 |
Colorectal Cancer | 8 | 1.5 | 4.33 |
Constipation | 2.5 | 1 | 1.5 |
Coronary artery disease | 2.5 | 1.5 | 0.67 |
COVID-19 | 19 | 22 | -0.16 |
Crohn's Disease | 13.5 | 9.5 | 0.42 |
cystic fibrosis | 1.5 | 1.5 | 0 |
deep vein thrombosis | 1.5 | 1.5 | 0 |
Depression | 16.5 | 14 | 0.18 |
Dermatomyositis | 0.5 | 0.5 | 0 |
Eczema | 2 | 3.5 | -0.75 |
Endometriosis | 5 | 2 | 1.5 |
Eosinophilic Esophagitis | 0.5 | 0.5 | 0 |
Epilepsy | 5 | 4.5 | 0.11 |
Fibromyalgia | 4.5 | 3.5 | 0.29 |
Functional constipation / chronic idiopathic constipation | 9.5 | 5.5 | 0.73 |
gallstone disease (gsd) | 3.5 | 1.5 | 1.33 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 3 | 1.5 | 1 |
Generalized anxiety disorder | 3.5 | 3 | 0.17 |
giant cell arteritis | 0.5 | -0.5 | |
Glioblastoma | 0.5 | -0.5 | |
Gout | 0.5 | -0.5 | |
Graves' disease | 2 | 2 | 0 |
Halitosis | 1.5 | 0.5 | 2 |
Hashimoto's thyroiditis | 4 | 1.5 | 1.67 |
Hidradenitis Suppurativa | 1.5 | 0.5 | 2 |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 5.5 | 1.5 | 2.67 |
hypercholesterolemia (High Cholesterol) | 1 | 1 | 0 |
hyperglycemia | 0.5 | 3.5 | -6 |
Hyperlipidemia (High Blood Fats) | 1.5 | 0.5 | 2 |
hypersomnia | 1 | -1 | |
hypertension (High Blood Pressure | 4 | 8 | -1 |
Hypothyroidism | 2 | -2 | |
Hypoxia | 1.5 | 1.5 | |
IgA nephropathy (IgAN) | 6 | -6 | |
Inflammatory Bowel Disease | 8 | 13 | -0.63 |
Insomnia | 1.5 | 1.5 | 0 |
Intelligence | 2 | 2 | |
Intracranial aneurysms | 2 | 0.5 | 3 |
Irritable Bowel Syndrome | 7.5 | 7 | 0.07 |
Liver Cirrhosis | 8 | 5.5 | 0.45 |
Long COVID | 14 | 14 | 0 |
Low bone mineral density | 1.5 | -1.5 | |
Lung Cancer | 1.5 | 2.5 | -0.67 |
ME/CFS with IBS | 2 | 4 | -1 |
ME/CFS without IBS | 3.5 | 3.5 | 0 |
Menopause | 3 | 3 | |
Metabolic Syndrome | 13.5 | 14.3 | -0.06 |
Mood Disorders | 21.5 | 14.5 | 0.48 |
multiple chemical sensitivity [MCS] | 2.5 | 0.5 | 4 |
Multiple Sclerosis | 10 | 8 | 0.25 |
Multiple system atrophy (MSA) | 3.5 | 1.5 | 1.33 |
Neuropathy (all types) | 1.5 | 0.5 | 2 |
neuropsychiatric disorders (PANDAS, PANS) | 1.5 | 1.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3 | 8.5 | -1.83 |
NonCeliac Gluten Sensitivity | 0.5 | -0.5 | |
Obesity | 14 | 8.5 | 0.65 |
obsessive-compulsive disorder | 11 | 6.5 | 0.69 |
Osteoarthritis | 4 | 0.5 | 7 |
Osteoporosis | 3 | 2 | 0.5 |
pancreatic cancer | 1 | 1 | |
Parkinson's Disease | 6 | 7 | -0.17 |
Polycystic ovary syndrome | 4 | 3.5 | 0.14 |
Postural orthostatic tachycardia syndrome | 0.5 | 1 | -1 |
Premenstrual dysphoric disorder | 1.5 | 0.5 | 2 |
primary biliary cholangitis | 0.5 | 1.5 | -2 |
Psoriasis | 7.5 | 4 | 0.88 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 10.5 | 6 | 0.75 |
Rosacea | 2 | 1 | 1 |
Schizophrenia | 11.5 | 3 | 2.83 |
scoliosis | 0.5 | 2 | -3 |
Sjögren syndrome | 4 | 5 | -0.25 |
Sleep Apnea | 2.5 | 2.5 | 0 |
Small Intestinal Bacterial Overgrowth (SIBO) | 2 | 1 | 1 |
Stress / posttraumatic stress disorder | 5 | 4.5 | 0.11 |
Systemic Lupus Erythematosus | 7.5 | 3 | 1.5 |
Tic Disorder | 2 | 1.5 | 0.33 |
Tourette syndrome | 0.5 | 0.5 | 0 |
Type 1 Diabetes | 6.5 | 4 | 0.63 |
Type 2 Diabetes | 14 | 12.3 | 0.14 |
Ulcerative colitis | 5 | 8.5 | -0.7 |
Unhealthy Ageing | 10.5 | 3.5 | 2 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.